NorthWest Health Prop Real Est Inv Trust (TSE:NWH.UN) Receives C$5.92 Average Target Price from Analysts

Shares of NorthWest Health Prop Real Est Inv Trust (TSE:NWH.UN) have been assigned a consensus recommendation of “Hold” from the seven ratings firms that are covering the firm, Marketbeat reports. Five analysts have rated the stock with a hold rating and two have issued a buy rating on the company. The average 1-year price objective among brokers that have covered the stock in the last year is C$5.92.

Several research analysts recently issued reports on NWH.UN shares. CIBC cut their price objective on NorthWest Health Prop Real Est Inv Trust from C$5.75 to C$5.50 in a research report on Thursday, August 15th. BMO Capital Markets upped their target price on shares of NorthWest Health Prop Real Est Inv Trust from C$5.00 to C$5.25 and gave the company a “market perform” rating in a report on Monday, May 27th. Finally, National Bankshares raised their price target on shares of NorthWest Health Prop Real Est Inv Trust from C$5.25 to C$5.75 and gave the stock a “sector perform” rating in a research note on Thursday, May 16th.

NorthWest Health Prop Real Est Inv Trust Trading Up 0.8 %

TSE:NWH.UN opened at C$5.11 on Friday. NorthWest Health Prop Real Est Inv Trust has a 52-week low of C$3.89 and a 52-week high of C$7.03. The company has a quick ratio of 0.06, a current ratio of 0.23 and a debt-to-equity ratio of 129.42. The stock has a fifty day simple moving average of C$4.95 and a 200-day simple moving average of C$4.84. The company has a market capitalization of C$1.26 billion, a PE ratio of -3.21, a price-to-earnings-growth ratio of 0.74 and a beta of 1.05.

NorthWest Health Prop Real Est Inv Trust Company Profile

NorthWest Healthcare Properties Real Estate Investment Trust (TSX: NWH.UN) (NorthWest) is an unincorporated, open-ended real estate investment trust established under the laws of the Province of Ontario. As at June 30, 2020, the REIT provides investors with access to a portfolio of high quality international healthcare real estate infrastructure comprised of interests in a diversified portfolio of 189 income-producing properties and 15.3 million square feet of gross leasable area located throughout major markets in Canada, Brazil, Europe, Australia and New Zealand.